Fig. 6: Clinical outcome following adoptive T cell therapy.
From: Compassionate access to virus-specific T cells for adoptive immunotherapy over 15 years
A The proportion of patients who were treated with the supplied T cell therapy. B The proportion of patients who displayed clinical improvement. C Representative analysis of viraemia relative to the administration of T cells for a patient with CMV complications. D Representative analysis of viraemia relative to the administration of T cells for a patient with AdV complications.
